During the past decade, Cornell Vascular conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cornell Vascular" are "Uterine Fibroids" (2 trials), "Breast Fibroadenoma" (1 trials), "Leiomyoma" (1 trials), "Uterine Leiomyoma" (1 trials) and "Uterine Leiomyomas" (1 trials). Many other conditions were trialed in "Cornell Vascular" in a lesser frequency.

Most popular intervention types in "Cornell Vascular" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "ExAblate 2000" (3 trials) and "ExAblate Enhanced Sonication" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cornell Vascular" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "Cornell Vascular". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cornell Vascular, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cornell Vascular, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".